Pregabalin for peripheral neuropathic pain.

Issues in emerging health technologies

Volumn , Issue 67, 2005, Pages 1-4

  Hadj Tahar, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG APPROVAL; DRUG COST; DRUG EFFECT; ECONOMICS; EUROPE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CANADA; DIABETIC NEUROPATHIES; DRUG APPROVAL; DRUG COSTS; EUROPE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 16244372426     PISSN: 14886324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)